These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32219146)

  • 1. Influence of Cytochrome P450 2D6 Polymorphisms on the Efficacy of Oral Propranolol in Treating Infantile Hemangioma.
    Wang L; Zheng K; Li X; Wang Y; Xu Q
    Biomed Res Int; 2020; 2020():8732871. PubMed ID: 32219146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
    Lee JY; Vinayagamoorthy N; Han K; Kwok SK; Ju JH; Park KS; Jung SH; Park SW; Chung YJ; Park SH
    Arthritis Rheumatol; 2016 Jan; 68(1):184-90. PubMed ID: 26316040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
    Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
    Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy.
    Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX
    Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
    Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
    Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol for infantile hemangioma: Effect on plasma vascular endothelial growth factor.
    Ozeki M; Nozawa A; Hori T; Kanda K; Kimura T; Kawamoto N; Fukao T
    Pediatr Int; 2016 Nov; 58(11):1130-1135. PubMed ID: 26991797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of VEGF and bFGF in infantile hemangiomas treated with propranolol.
    Şen HS; Yalçın B; Canpınar H; Ocak S; Akyüz C
    Turk J Pediatr; 2020; 62(6):979-985. PubMed ID: 33372436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment.
    Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K
    Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the CYP2D6 enzymatic activity based on investigating of the CYP2D6 genotypes around the vivax malaria patients in Yunnan Province, China.
    Dong Y; Huang H; Deng Y; Xu Y; Chen M; Liu Y; Zhang C
    Malar J; 2021 Nov; 20(1):448. PubMed ID: 34823523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma.
    Aydin Köker S; Kömüroğlu AU; Köksoy AY; Şiraz ÜG; Tekin E; Köker A
    Arch Pediatr; 2021 May; 28(4):296-300. PubMed ID: 33715934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma.
    Makkeyah SM; Elseedawy ME; Abdel-Kader HM; Mokhtar GM; Ragab IA
    Pediatr Hematol Oncol; 2022 Apr; 39(3):215-224. PubMed ID: 34477031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
    Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
    J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing and Evaluating the HRM Technique for Identifying Cytochrome P450 2D6 Polymorphisms.
    Lu HC; Chang YS; Chang CC; Lin CH; Chang JG
    J Clin Lab Anal; 2015 May; 29(3):220-5. PubMed ID: 24798984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
    Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö
    Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CYP2D6 and β2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis.
    Zhang F; Duan X; Zhang M; Li Z; He Q; Wang Y; Miao C; Zhong W; Zou X; Zhuge Y
    J Gastroenterol Hepatol; 2016 Apr; 31(4):829-34. PubMed ID: 26489037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol therapy for infantile hemangioma: our experience.
    Zhang L; Wu HW; Yuan W; Zheng JW
    Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
    Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
    Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.
    Yuan WL; Jin ZL; Wei JJ; Liu ZY; Xue L; Wang XK
    Br J Oral Maxillofac Surg; 2013 Oct; 51(7):656-61. PubMed ID: 23291092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.